- The journal uses a double-blind peer-review process for research and review of manuscripts.
- Each submission is first assessed by the editorial office and the handling editor for suitability, originality, scientific quality, and compliance with the journal's policies.
- Manuscripts that pass initial screening are sent to at least two independent reviewers with relevant subject expertise.
- Final decisions are made by the handling editor or the Editor-in-Chief based on reviewer reports, editorial assessment, and the journal's standards for quality and integrity.
- Editors may reject submissions without external review if they are outside scope, scientifically inadequate, ethically non-compliant, or insufficiently original.
Instructions for authors
The journal welcomes submissions that are original, scientifically rigorous, and relevant to molecular medicine, translational biomedicine, and biotechnology. Manuscripts must not be under 2 consideration elsewhere and must comply with the journal's editorial, ethical, and reporting standards.
Article types
- Original Research Articles.
- Review Articles.
- Systematic Reviews and Meta-Analyses.
- Short Communications.
- Methods and Technical Reports.
- Clinical and Translational Studies.
- Perspectives, Commentaries, and Editorials.
- Special Issue Articles by invitation or approved proposal.
Submission requirements
- Manuscripts must be written in clear academic English and prepared according to the journal's formatting instructions.
- A title page should include the full title, author names, affiliations, corresponding author details, and relevant identifiers where available.
- Abstracts and keywords are required for all research and review content.
- Figures and tables must be high quality, clearly labeled, and appropriately cited in the text.
- Figure and table quality are part of the journal quality assessment in the indexing review.
- References must be accurate, complete, and formatted according to journal style.
- Authors should include statements on funding, conflicts of interest, author contributions, data availability, and ethical approval where applicable.
- Clinical, animal, and human-subjects research must include ethics committee approval details and consent statements where required.
Editorial screening criteria
Submissions are assessed for fit with scope, scientific validity, originality, clarity, ethical compliance, and potential significance. Manuscripts that do not meet basic editorial or ethical requirements may be returned without external review.
Copyright and licensing
All published articles should clearly state copyright and licensing terms on the article itself and on the journal website. Open-access content is expected to use a clearly described open license, with Creative Commons licensing commonly adopted for this purpose.
Archiving and preservation
Correspondence: Letters to the Editor that comment directly on work that has previously been published in the journal will be considered. The author of the paper on which the Letter is commenting will be contacted and invited to respond. In addition, journal will consider letters on unique cases or observations of interest to the journal's readership. Letters have a limit of 1,000 words and should be structured as a Letter, without an abstract or keywords.
Case Reports: The journal will consider unique cases or a unique series of cases of interest and relevance to the journal's readership. They should be a maximum of 1,500 words, contain a structured abstract, and have no more than ten references.
Submission declaration
When authors submit an article to a journal, it is implied that the work described has not been published previously. The article is not under consideration for publication elsewhere. The article's publication is approved by all authors and, tacitly or explicitly, by the responsible authorities at the institution where the work was carried out. if accepted, the article will not be published elsewhere in the same form, in English or in any other language, including electronically, without the written consent of the copyright-holder.
Authorship
All authors should have made substantial contributions to all of the following:
1. The conception and design of the study, or acquisition of data, or analysis and interpretation of data
2. Drafting the article or revising it critically for important intellectual content.
3. Final approval of the version to be submitted.
All authors are accountable for all aspects of the work to ensure that questions regarding the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Authors should appoint a single corresponding author to communicate with the journal during the editorial process. This individual submits the manuscript and all required documentation to the journal and serves as the primary contact between the journal and the co-authors.
Changes to authorship
The editors of this journal generally will not consider changes to authorship once a manuscript has been submitted. It is important that authors carefully consider the authorship list and order of authors and provide a definitive author list at submission. All authors must be listed in the manuscript and their details entered into the submission system. Changes can only be made prior to acceptance, and only if approved by the journal editor. This includes additions, deletion, or rearrangement of author names. Requests to change authorship must be made by the corresponding author using the Authorship Change Request form. The corresponding author must provide the reason for the request to the journal editor with written confirmation from all authors, including any authors being added or removed, that they agree with the changes. Requests which do not comply with the instructions outlined in the form will not be considered. This journal does not allow authorship changes after acceptance.
Cover letter
A cover letter that includes the following information, as well as any additional information requested in the instructions for your specific article type (see Prepare your manuscript): An explanation of why your manuscript should be published in Molecular Medicine and Biotechnology Advances (Mol. Med. Biotechnol. Adv.) An explanation of any issues relating to journal policies.
A declaration of any potential competing interests. Confirmation that all authors have approved the manuscript for submission. Confirmation that the content of the manuscript has not been published, or submitted for publication elsewhere (see our Duplicate publication policy). If you are submitting a manuscript to a particular special issue, please refer to its specific name in your covering letter.
Peer reviewers
In your cover letter, you may suggest potential peer reviewers for your manuscript. If you wish to do so, please provide institutional email addresses where possible, or information that will help the Editor to verify the identity of the reviewer (for example, an ORCID or Scopus ID).
Intentionally falsifying information, for example, suggesting reviewers with a false name or email address, will result in rejection of your manuscript and may lead to further investigation in line with our misconduct policy. You may also enter details of anyone whom you would prefer not to review your manuscript in your cover letter.
Declarations’ section
Declarations' section before the reference list under a heading of ‘Consent to participate’ and/or ‘Consent to publish’. Other declarations include Funding, Competing interests, Ethics approval, Consent, Data and/or Code availability, and Authors’ contribution statements.
- Sample statements for "Consent to participate"
- Informed consent was obtained from all individual participants included in the study.
- Informed consent was obtained from legal guardians.
- Written informed consent was obtained from the parents.
- Verbal informed consent was obtained prior to the interview.
- Sample statements for “Consent to publish”:
- The authors affirm that human research participants provided informed consent for publication of the images in Figure(s) 1a, 1b, and 1c.
- The participant has consented to the submission of the case report to the journal.
- Patients signed informed consent forms regarding the publication of their data and photographs.
Sample statements if identifying information about participants is available in the article:
Additional informed consent was obtained from all individual participants for whom identifying information is included in this article. Authors are responsible for the correctness of the statements provided in the manuscript. The Editor-in-Chief reserves the right to reject submissions that do not meet the guidelines described in this section. Images will be removed from publication if authors have not obtained informed consent, or the paper may be removed and replaced with a notice explaining the reason for removal.
Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of Potential competing interests include:
- Employment
- Consultancies
- Stock ownership
- Honoraria
- Paid expert testimony
- Patent applications or registrations
- Grants or any other funding
- Affiliation with the journal as an Editor or Advisory Board Member
- The declarations tool should always be completed.
Authors with a journal affiliation to declare should enter the following text under “Other Activities” within the declarations tool should inform the journal and publisher Prior to completing the submission process:
Editorial disclosure statements will be included as a footnote and/or in the declaration of competing interest section of the article. Authors with no competing interests to declare should select the option "I have nothing to declare". The resulting Word document containing your declaration should be uploaded at the "attach/upload files" step in the submission process. It is important that the Word document is saved in the .doc or .docx format. Author signatures are not required.
Funding sources
Authors must disclose any funding sources that provided financial support for the conduct of the research and/or preparation of the article. The role of sponsors, if any, should be declared in relation to the study design, collection, analysis, and interpretation of data, writing of the report, and decision to submit the article for publication. If funding sources had no such involvement, this should be stated in your submission. List funding sources in this standard way to facilitate compliance to funder's requirements:
Funding: This work was supported by the National Institutes of Health [grant numbers xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle, WA [grant number zzzz]; and the United States Institute of Peace [grant number xxx]. It is not necessary to include detailed descriptions of the program or of the types of grants, scholarships, and awards. When funding is from a block grant or other resources available to a university, college, or other research institution,submit the name of the institute or organization that provided the funding. If no funding has been provided for the research, it is recommended to include the The following sentence:
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.
Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use. Authors preparing a manuscript for this journal may use AI tools to support them. However, these tools must never be used as a substitute for human critical thinking, expertise, and evaluation. AI tools may be used only with human oversight and control. Finally, authors must not list or cite AI tools as authors or co-authors on the manuscript, since authorship implies responsibilities and tasks that can only be attributed to and performed by humans. The use of AI tools in the manuscript preparation process must be declared by adding a statement at the end of the manuscript upon first submission. The statement will appear in the published work and should be placed in a new section before the references list. An example:
Title of new section: Declaration of generative AI and AI-assisted technologies in the manuscript preparation process.
Statement: During the preparation of this work, the author(s) used [NAME OF TOOL / SERVICE] in order to [REASON]. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the published article.
The declaration does not apply to the use of basic tools, such as those for checking grammar, spelling, and references. In addition, authors are not required to disclose the use of AI tools or features within specialist disability-related assistive technology, provided that such tools or features are used solely for accessibility purposes. If you have nothing to disclose, you do not need to add a statement.
